Clinical trial Recruiting at 1 site Interventional Ages 1 Year to 18

Using Tranexamic Acid to Reduce Blood Loss in Pediatric Hip Surgery

Official title: Impact of Tranexamic Acid Use on Blood Loss and Transfusion Rates After Hip Reconstruction in Children, A Randomized Controlled Trial

Run by Assiut University · NCT04811313 · Data updated 2026-11-12

This study is testing if giving tranexamic acid can help reduce blood loss during hip surgery in children and lower the chances they need a blood transfusion.

Quick facts

Study typeInterventional
Ages1 Year to 18 Years
SexAll
Enrollment400 (estimated)
SponsorAssiut University
Academic / other
Locations1 site (Asyut)
StatusRecruiting
StartedApril 3, 2025
Main results expectedJanuary 2026
Study endsMarch 2026
Registry record updatedNovember 17, 2025
Trial IDNCT04811313 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pediatric patients classified as ASA I-II who are scheduled for acetabular or proximal femoral osteotomies.

Probably not a fit

Patients with pre-existing bleeding disorders, anemia, or those whose guardians refuse participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of tranexamic acid (TXA), an antifibrinolytic agent, in reducing intraoperative blood loss and the need for blood transfusions in pediatric patients undergoing proximal femoral and acetabular osteotomies. The trial compares outcomes between patients receiving TXA and those receiving a placebo. By promoting hemostasis and preventing fibrin degradation, TXA aims to improve surgical outcomes in this vulnerable population. The study is designed to fill the gap in existing literature regarding the safety and efficacy of TXA in pediatric orthopedic procedures.

Why it matters

Potential benefit: If successful, this approach could significantly reduce blood loss and transfusion needs during pediatric hip surgeries, leading to better recovery outcomes.

How similar studies have gone: While TXA has shown success in adult orthopedic surgeries and pediatric cardiac procedures, its application in pediatric orthopedic surgeries is less explored, making this study a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ASA I - II
* Scheduled for acetabular osteotomy and/or proximal femoral derotation osteotomies.

Exclusion Criteria:

* Patient's guardian refusal to participate in the study.
* Children known to have pre-existing bleeding or coagulation disorders.
* Children with anemia; defined according to (WHO ) cutoffs as Hb level\<11g/dl for girls and \<12g/dl for boys
* History of epilepsy.
* History of renal insufficiency or failure

Where it's running

  • Assiut University
    Asyut, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.